July 16, 2026 – EllieMD™ has announced the launch of its new Hormone Replacement Therapy (HRT) product line, marking a major step in the company’s mission to make evidence-based healthcare more accessible. The new offering is designed to support millions of women experiencing menopause while expanding access to physician-guided preventive care.
The company says the launch is more than a product expansion. It reflects EllieMD’s long-term commitment to advancing self-health solutions and helping people find personalized wellness options.
Launched in June 2026, the new Hormone Replacement Therapy (HRT) products are designed to serve the nearly 50 million women in the United States experiencing menopause symptoms.
According to EllieMD, nearly 75% of menopausal women do not receive treatment for their symptoms. The company aims to close this gap by providing easier access to medically guided hormone therapy through its healthcare platform.
The introduction of EllieMD’s HRT products comes shortly after the U.S. Food and Drug Administration (FDA) updated its hormone therapy labeling by removing certain warnings that were no longer supported by current scientific evidence.
EllieMD believes these regulatory changes create new opportunities for women to make informed healthcare decisions based on the latest medical research and physician guidance.
EllieMD combines telehealth services, licensed healthcare providers, and a relationship-driven distribution model to improve access to preventive care.
The company says its healthcare approach focuses on empowering individuals through personalized treatment options while making medical support more convenient and accessible.
Hanieh Sigari, Founder and CEO of EllieMD, said many women spent years avoiding hormone therapy because of outdated information. She noted that modern scientific evidence is changing how preventive healthcare is viewed.
Sigari added that EllieMD is committed to making physician-guided, evidence-based preventive care available before serious health conditions develop. The company also plans to continue promoting education, challenging outdated beliefs, and improving healthcare access for more communities.
EllieMD recently received the Bravo Innovator Award, recognizing the company’s innovative approach to modern healthcare. By combining digital health technology with medical expertise, EllieMD continues to expand its portfolio of patient-focused wellness solutions.
The launch of the new Hormone Replacement Therapy line strengthens EllieMD’s position in women’s health and preventive medicine. As demand for personalized healthcare continues to grow, the company remains focused on delivering science-backed solutions that improve long-term health outcomes and quality of life.
There are no reviews yet. Be the first one to write one.
